Christobel Selecky's most recent trade in ImmunityBio Inc was a trade of 50,000 Common Stock done at an average price of $3.0 . Disclosure was reported to the exchange on Jan. 16, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| ImmunityBio Inc | Christobel Selecky | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.98 per share. | 16 Jan 2026 | 50,000 | 50,000 | - | 3.0 | 149,000 | Common Stock |
| ImmunityBio Inc | Christobel Selecky | Director | Sale of securities on an exchange or to another person at price $ 5.00 per share. | 16 Jan 2026 | 50,000 | 0 | - | 5 | 250,000 | Common Stock |
| ImmunityBio Inc | Christobel Selecky | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jan 2026 | 50,000 | 117,937 | - | - | Stock Option (right to buy) | |
| ImmunityBio Inc | Christobel Selecky | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.98 per share. | 16 Jan 2026 | 25,000 | 25,000 | - | 3.0 | 74,500 | Common Stock |
| ImmunityBio Inc | Christobel Selecky | Director | Sale of securities on an exchange or to another person at price $ 7.51 per share. | 16 Jan 2026 | 25,000 | 0 | - | 7.5 | 187,650 | Common Stock |
| ImmunityBio Inc | Christobel Selecky | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jan 2026 | 25,000 | 92,937 | - | - | Stock Option (right to buy) | |
| ImmunityBio Inc | Christobel Selecky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 162,786 | 162,786 | - | - | Stock Option (right to buy) | |
| ImmunityBio Inc | Christobel Selecky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 77,633 | 77,633 | - | - | Stock Option (right to buy) | |
| ImmunityBio Inc | Christobel Selecky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 158,263 | 158,263 | - | - | Stock Option (right to buy) | |
| ImmunityBio Inc | Christobel Selecky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2022 | 167,937 | 167,937 | - | - | Stock Option (right to buy) | |
| ImmunityBio Inc | Christobel Selecky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 26,064 | 26,064 | - | - | Stock Option (right to buy) | |
| ImmunityBio Inc | Christobel Selecky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2021 | 21,873 | 21,873 | - | - | Stock Option (right to buy) |